Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Reexamination Certificate
2006-04-18
2006-04-18
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
Reexamination Certificate
active
07030157
ABSTRACT:
The present invention relates to pharmaceutical compositions, kits and methods comprising combinations of (−)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol or nontoxic pharmacologically acceptable acid addition salts thereof and estrogens. The present invention also relates to pharmaceutical compositions, kits and methods comprising combinations of (−)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol or nontoxic pharmacologically acceptable acid addition salts thereof, estrogens and progestins.
REFERENCES:
patent: 5183814 (1993-02-01), Dukes
patent: 5510357 (1996-04-01), Palkowitz
patent: 5510358 (1996-04-01), Palkowitz
patent: 5534527 (1996-07-01), Black et al.
patent: 5552401 (1996-09-01), Cullinan et al.
patent: 5843984 (1998-12-01), Clay et al.
patent: 5891868 (1999-04-01), Cummings et al.
patent: 5962475 (1999-10-01), Schmid et al.
patent: 6107331 (2000-08-01), MacLean et al.
patent: 2002/0013327 (2002-01-01), Lee et al.
patent: 2002/0128276 (2002-09-01), Day et al.
patent: 0665015 (1995-08-01), None
patent: 0 792 641 (1997-03-01), None
patent: 0838464 (1998-04-01), None
patent: 0888775 (1999-01-01), None
patent: 0953568 (1999-11-01), None
patent: 0966968 (1999-12-01), None
patent: 0835868 (2001-08-01), None
patent: 1149579 (2001-10-01), None
patent: 1106179 (2003-06-01), None
patent: WO 9709348 (1997-03-01), None
patent: WO 9716434 (1997-05-01), None
patent: WO 97/31640 (1997-09-01), None
patent: WO 9840076 (1998-09-01), None
patent: WO 9924027 (1999-05-01), None
patent: WO 9939581 (1999-08-01), None
patent: WO 9953910 (1999-10-01), None
patent: WO 9959581 (1999-11-01), None
patent: WO 9959969 (1999-11-01), None
patent: WO 9963974 (1999-12-01), None
patent: WO 0007598 (2000-02-01), None
patent: WO 0067708 (2000-11-01), None
patent: WO 0074684 (2000-12-01), None
patent: WO 0126640 (2001-04-01), None
patent: WO 0154699 (2001-08-01), None
Berman, J.R., et al.,Urology, “Female Sexual Dysfunction: Incidence, Pathophysiology, Evaluation, and Treatment Options”, vol. 54, pp. 385-391 (1999).
International PCT Search Report relating to PCT/IB02/02763.
Ke, H., et al.,Journal of Bone and Mineral Research“Co-Treatment of Lasofoxifene (CP-336,156) and Estrogen Inhibits Estrogen's Effect in the Uterus But Maintains the Bone Protective Effects in Ovariectomized Rats”, p. S310 (2000).
Rosati, R.L., et al.,J. Med. Chem., “Discovery and Preclinical Pharmacology of a Novel, Potent, Nonsteroidal Estrogen Receptor Agonist/Antagonist, CP-336156, a Diaryltetrahydronaphtalene”, vol. 41, pp. 2928-2931 (1998).
Gegnas, L.D.,Expert Opinion on Therapeutic Patents, “Osteoporosis Therapies”, vol. 10, No. 6, pp. 833-846 (2000).
Journal of Bone and Mineral Research, vol. 15, No. Suppl. 1, pp. S310, 22ndAnnual Meeting of the American Society for Bone & Mineral Research, Toronto, Ontario, Canada, Sep. 22-26, 2000.
Cooper, et al.,British Journal of Obstetrics and Gynecology, “A Randomized Pilot Study of HRT in Patients with Breast Cancer: The Combined Effects of Tomoxifen and HRT on the Endometrium”, vol. 105, Suppl. 17 p. 15 (1998).
Snyder, et al.,Am. J. Health-Syst. Pharm.“Raloxifene Hydrochloride”, vol. 57, pp. 1669-1675 (2000).
Ke HuaZhu
Thompson David D.
Benson Gregg C.
Hui San-Ming
Pfizer Inc.
Wichtowski John A.
LandOfFree
Pharmaceutical compositions, kits and methods comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions, kits and methods comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions, kits and methods comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595847